missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ RNF12 Polyclonal Antibody

Rabbit Polyclonal Antibody
Marca: Invitrogen™ PA540489
Este artículo no se puede devolver.
Vea la política de devoluciones
Descripción
Peptide sequence: AQFFLLNEDD DDQPRGLTKE QIDNLAMRSF GENDALKTCS VCITEYTEGN Sequence homology: Cow: 100%; Dog: 100%; Guinea Pig: 93%; Horse: 100%; Human: 100%; Mouse: 93%; Pig: 100%; Rabbit: 100%; Rat: 93%; Yeast: 89%; Zebrafish: 93%.
RNF12 is a RING-H2 zinc finger protein. It has been shown to be a ubiquitin protein ligase that targets LIM domain binding 1 (LDB1/CLIM), and causes proteasome-dependent degradation of LDB1. This protein and LDB1 are co-repressors of LHX1/LIM-1, a homeodomain transcription factor. Alternatively spliced transcript variants encoding the same protein have been reported.
Especificaciones
| RNF12 | |
| Polyclonal | |
| Unconjugated | |
| RLIM | |
| AL022832; AW743871; CTD-2530H13.3; DKFZp686N06224; E3 ubiquitin-protein ligase RLIM; E3 ubiquitin-protein ligase RNF12; FLJ25923; FLJ41093; FLJ42887; FLJ45986; Ha1r; Hoxa1 regulated; LIM domain-interacting RING finger protein; MGC15161; NY-REN-43; renal carcinoma antigen NY-REN-43; RING finger LIM domain-binding protein; ring finger protein 12; ring finger protein, LIM domain interacting; ring zinc finger LIM domain binding protein; ring zinc finger protein NY-REN-43antigen; RING-type E3 ubiquitin transferase RLIM; Rlim; R-LIM; Rlim1; RNF12 | |
| Rabbit | |
| Affinity Chromatography | |
| RUO | |
| 51132 | |
| -20°C, Avoid Freeze/Thaw Cycles | |
| Liquid |
| Immunohistochemistry, Western Blot | |
| 0.5 mg/mL | |
| PBS with 2% sucrose and 0.09% sodium azide | |
| Q9NVW2 | |
| RLIM | |
| Synthetic peptide directed towards the C-terminal of human RNF12 (aa 532-581). | |
| 100 μL | |
| Primary | |
| Human | |
| Antibody | |
| IgG |
Corrección del contenido de un producto
Proporcione sus comentarios sobre el contenido del producto rellenando el siguiente formulario.
Título del producto
¿Detecta una oportunidad de mejora?Comparta una corrección de contenido